MedTrace Logo

Diagnosis and Management of Arterial Hypertension for Algerian Patients in Current Medical Practice

NCT03607812 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1027

Last updated 2019-08-20

No results posted yet for this study

Summary

Blood pressure reduction and control are associated with reduced risk of stroke and cardiovascular disease. There is evidence that ambulatory blood pressure monitoring (ABPM) results more accurately reflect the risk of cardiovascular events than do office measurements of blood pressure. New international guidelines recognize the importance of ABPM which has an important and growing role in the diagnosis and in guiding antihypertensive therapy. In 2011 in the United Kingdom, the National Institute for Health and Care Excellence (NICE) recommended that ABPM be performed on all patients with suspected hypertension to confirm the diagnosis and reduce unnecessary treatment in people who do not have true hypertension. The aim of this observational study is to describe the utility of ABPM generally and specifically in the management of hypertension by Cardiologists in the Algerian context.

Conditions

  • Arterial Hypertension

Sponsors & Collaborators

  • Axelys Sante Dz

    collaborator INDUSTRY

  • Merinal Laboratoires

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-28
Primary Completion
2018-07-31
Completion
2018-08-31

Countries

  • Algeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03607812 on ClinicalTrials.gov